168 related articles for article (PubMed ID: 34653726)
1. Presentation and survival by hormonal receptor status in metaplastic breast cancer: A propensity score-matched analysis.
Wang S; Hu J; Zhang Y; Shen J; Dong F; Zhang X; Lu C; Shang D
Breast; 2021 Dec; 60():168-176. PubMed ID: 34653726
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database.
Hu J; Tan J; Dong F; Zhang X; Ming J; Huang T
Front Oncol; 2021; 11():593121. PubMed ID: 35096554
[TBL] [Abstract][Full Text] [Related]
3. The Effect of HER2 Status on Metaplastic Breast Cancer A Propensity Score-Matched Analysis.
Hu J; Zhang Y; Dong F; Shen J; Chen H; Li L; Huang T
Front Endocrinol (Lausanne); 2022; 13():874815. PubMed ID: 35928894
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database.
Wang J; Zhang WW; Lian CL; Sun JY; He ZY; Wu SG
Front Oncol; 2019; 9():747. PubMed ID: 31475106
[No Abstract] [Full Text] [Related]
5. The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.
Li Y; Chen M; Pardini B; Dragomir MP; Lucci A; Calin GA
J Transl Med; 2019 Sep; 17(1):318. PubMed ID: 31547814
[TBL] [Abstract][Full Text] [Related]
6. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
7. Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype.
Mao J; Hu J; Zhang Y; Shen J; Dong F; Zhang X; Ming J; Huang T; Run X
Front Endocrinol (Lausanne); 2021; 12():628939. PubMed ID: 33972826
[TBL] [Abstract][Full Text] [Related]
8. The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study.
Xia LY; Xu WY; Hu QL
PLoS One; 2021; 16(9):e0256893. PubMed ID: 34473783
[TBL] [Abstract][Full Text] [Related]
9. Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.
Wang Y; Chen K; Yang Y; Tan L; Chen L; Zhu L; Su F; Liu X; Li S
Ann Transl Med; 2019 Oct; 7(20):536. PubMed ID: 31807518
[TBL] [Abstract][Full Text] [Related]
10. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract][Full Text] [Related]
11. Metaplastic breast cancer: Treatment and prognosis by molecular subtype.
Hu J; Zhang H; Dong F; Zhang X; Wang S; Ming J; Huang T
Transl Oncol; 2021 May; 14(5):101054. PubMed ID: 33677236
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of breast reconstruction for N2-3M0 stage female breast cancer on breast cancer-specific survival: A population-based propensity score analysis.
Zhao Y; Yan L; Li S; Yang Z; Chai N; Qiu P; Zhang H; He J; Zhou C
Cancer Med; 2023 Oct; 12(20):20287-20298. PubMed ID: 37795774
[TBL] [Abstract][Full Text] [Related]
13. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma.
Wu SG; Yang SP; Zhang WW; Wang J; Lian CL; Chen YX; He ZY
Sci Rep; 2020 Dec; 10(1):22070. PubMed ID: 33328559
[TBL] [Abstract][Full Text] [Related]
14. Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database.
McMurtry V; Cleary AS; Ruano AL; Lomo L; Gulbahce HE
Am J Clin Oncol; 2023 Dec; 46(12):559-566. PubMed ID: 37705411
[TBL] [Abstract][Full Text] [Related]
15. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis.
Lin Y; Huang K; Zeng Q; Zhang J; Song C
PeerJ; 2020; 8():e8694. PubMed ID: 32219021
[TBL] [Abstract][Full Text] [Related]
16. Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis.
Lian W; Zheng J; Chen D
Transl Cancer Res; 2020 Oct; 9(10):5969-5978. PubMed ID: 35117209
[TBL] [Abstract][Full Text] [Related]
17. The Role of Adjuvant Chemotherapy in Metaplastic Breast Carcinoma: A Competing Risk Analysis of the SEER Database.
Lan T; Lu Y; Zheng R; Shao X; Luo H; He J; Yang H; Xu H; Wang X; Hu Z
Front Oncol; 2021; 11():572230. PubMed ID: 33981594
[No Abstract] [Full Text] [Related]
18. Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis.
Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Younus J; Perera F; Tai P
Cureus; 2015 Oct; 7(10):e355. PubMed ID: 26623210
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival.
Narayan P; Kostrzewa CE; Zhang Z; O'Brien DAR; Mueller BA; Cuaron JJ; Xu AJ; Bernstein MB; McCormick B; Powell SN; Khan AJ; Wen HY; Braunstein LZ
Breast Cancer Res Treat; 2023 Jun; 199(2):355-361. PubMed ID: 36976395
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Analysis of Primary Breast Signet Ring Cell Carcinoma and Mucinous Breast Adenocarcinoma: A SEER Population-Based Study.
Wang S; Zhang Y; Yin F; Zhang X; Yang Z; Wang X
Front Oncol; 2021; 11():783631. PubMed ID: 34956901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
